Westhampton Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Buy |
46,778
+4,200
| +10% | +$102K | 0.59% | 54 |
|
|
2025
Q1 | $1.08M | Buy |
42,578
+400
| +0.9% | +$10.1K | 0.59% | 57 |
|
|
2024
Q4 | $1.12M | Buy |
42,178
+500
| +1% | +$13.3K | 0.57% | 57 |
|
|
2024
Q3 | $1.21M | Buy |
41,678
+9,900
| +31% | +$287K | 0.61% | 55 |
|
|
2024
Q2 | $889K | Buy |
31,778
+525
| +2% | +$14.7K | 0.48% | 65 |
|
|
2024
Q1 | $867K | Buy |
31,253
+5,100
| +20% | +$142K | 0.47% | 65 |
|
|
2023
Q4 | $753K | Sell |
26,153
-300
| -1% | -$8.64K | 0.45% | 68 |
|
|
2023
Q3 | $877K | Sell |
26,453
-150
| -0.6% | -$4.98K | 0.57% | 59 |
|
|
2023
Q2 | $976K | Sell |
26,603
-330
| -1% | -$12.1K | 0.63% | 52 |
|
|
2023
Q1 | $1.1M | Buy |
26,933
+100
| +0.4% | +$4.08K | 0.71% | 50 |
|
|
2022
Q4 | $1.37M | Buy |
26,833
+500
| +2% | +$25.6K | 0.93% | 42 |
|
|
2022
Q3 | $1.15M | Hold |
26,333
| – | – | 0.87% | 43 |
|
|
2022
Q2 | $1.38M | Buy |
26,333
+300
| +1% | +$15.7K | 0.98% | 36 |
|
|
2022
Q1 | $1.35M | Hold |
26,033
| – | – | 0.87% | 40 |
|
|
2021
Q4 | $1.54M | Hold |
26,033
| – | – | 0.94% | 37 |
|
|
2021
Q3 | $1.12M | Sell |
26,033
-198
| -0.8% | -$8.52K | 0.77% | 44 |
|
|
2021
Q2 | $1.03M | Buy |
26,231
+250
| +1% | +$9.79K | 0.67% | 50 |
|
|
2021
Q1 | $941K | Buy |
25,981
+2,400
| +10% | +$86.9K | 0.65% | 49 |
|
|
2020
Q4 | $868K | Buy |
23,581
+97
| +0.4% | +$3.57K | 0.65% | 48 |
|
|
2020
Q3 | $818K | Buy |
23,484
+237
| +1% | +$8.26K | 0.67% | 48 |
|
|
2020
Q2 | $721K | Sell |
23,247
-432
| -2% | -$13.4K | 0.63% | 49 |
|
|
2020
Q1 | $733K | Hold |
23,679
| – | – | 0.76% | 43 |
|
|
2019
Q4 | $880K | Sell |
23,679
-274
| -1% | -$10.2K | 0.71% | 43 |
|
|
2019
Q3 | $817K | Sell |
23,953
-42
| -0.2% | -$1.43K | 0.68% | 45 |
|
|
2019
Q2 | $986K | Buy |
+23,995
| New | +$986K | 0.83% | 39 |
|